Correlation Between Camurus AB and NextCell Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Camurus AB and NextCell Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Camurus AB and NextCell Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Camurus AB and NextCell Pharma AB, you can compare the effects of market volatilities on Camurus AB and NextCell Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Camurus AB with a short position of NextCell Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Camurus AB and NextCell Pharma.

Diversification Opportunities for Camurus AB and NextCell Pharma

0.75
  Correlation Coefficient

Poor diversification

The 3 months correlation between Camurus and NextCell is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Camurus AB and NextCell Pharma AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NextCell Pharma AB and Camurus AB is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Camurus AB are associated (or correlated) with NextCell Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NextCell Pharma AB has no effect on the direction of Camurus AB i.e., Camurus AB and NextCell Pharma go up and down completely randomly.

Pair Corralation between Camurus AB and NextCell Pharma

Assuming the 90 days trading horizon Camurus AB is expected to generate 1.06 times less return on investment than NextCell Pharma. But when comparing it to its historical volatility, Camurus AB is 1.7 times less risky than NextCell Pharma. It trades about 0.32 of its potential returns per unit of risk. NextCell Pharma AB is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest  286.00  in NextCell Pharma AB on November 27, 2024 and sell it today you would earn a total of  44.00  from holding NextCell Pharma AB or generate 15.38% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Camurus AB  vs.  NextCell Pharma AB

 Performance 
       Timeline  
Camurus AB 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Camurus AB are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Camurus AB unveiled solid returns over the last few months and may actually be approaching a breakup point.
NextCell Pharma AB 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in NextCell Pharma AB are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, NextCell Pharma unveiled solid returns over the last few months and may actually be approaching a breakup point.

Camurus AB and NextCell Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Camurus AB and NextCell Pharma

The main advantage of trading using opposite Camurus AB and NextCell Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Camurus AB position performs unexpectedly, NextCell Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NextCell Pharma will offset losses from the drop in NextCell Pharma's long position.
The idea behind Camurus AB and NextCell Pharma AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities